Introduction
Blood coagulation testing measures the time of onset of blood clotting, which involves an activating cascade of coagulation factors that ends with the formation of a cross-linked fibrin clot. Coagulation time tests are required for patients who are receiving anticoagulant therapy 1 , undergoing pre-operation evaluation 2 , or suffering from hepatic or renal disorders 3 , monitoring the disease progression such as dengue hemorrhagic fever 4 . Also patients with a risk of embolism, stroke or atrial fibrillation require their coagulation time to be measured and adjusted periodically by suitable oral anticoagulants. Thus, fast, reliable and simple assays are needed to monitor the coagulation parameters 5, 6 . Prothrombin time (PT) and activated partial thromboplastin time (aPTT) are the most frequently performed tests to determine the functionality of the blood coagulation system 7 . The measurement of PT and aPTT depends on activation by the tissue factor (extrinsic system) or surface (intrinsic system), respectively. In clinical use, aPTT is performed by manually mixing blood plasma samples with phospholipids and an activator (silica, celite, kaolin or ellagic acid). For the PT test, a reagent containing tissue factor is added to a plasma sample to induce coagulation through the extrinsic pathway. In general practice, patients need to visit a hospital or a central laboratory periodically for coagulation tests. Such a procedure puts a significant burden on the health-care provider and increases the return time and the cost of the test. To alleviate these problems, some portable devices have been developed for PT measurements 8, 9 . Although these systems are practical and require low sample volume, they are capable of conducting only one type of measurement with one sample. There is no commercial device which is suitable for both PT and aPTT measurements. These tests give specific information about intrinsic and extrinsic pathways which are not independent from each other 10 . Hence obtaining both of the results enables a more comprehensive assessment. Furthermore, these devices require electrical connections between the disposable cartridge and the analyser unit which can create reliability problems in long-term use. On the other side, the system developed in this study measures the clot-time directly by monitoring the mechanical properties of blood with a non- contact actuation and detection method. Also it is the only platform that can perform multiple tests with the same sample. There have been recent studies to measure clot-time with low sample volumes using MEMS and microfluidics technology. Magnetoelastic sensors 11, 12 , Quartz Crystal Microbalance (QCM) [13] [14] [15] and Contour-Mode Film Bulk Acoustic Resonator (C-FBAR) based techniques 16 have been utilized to measure coagulation times. However in these studies mixing of the blood samples with the reagents were conducted manually on the sensors. Hence, functionalized sensors with microfluidic platforms are not proposed. A commercial device 17 based on static mode microcantilevers is in preparation for launch soon. These cantilevers require electrical connections to the cartridge due to the use of piezo-resistive elements for sensing and actuation 18 . Microfluidic devices is also used for aPTT test 19 and PT test 20 . To the best of our knowledge, the studies in the published literature are limited to single tests and not multiplexed. Most of the clinical applications require, both PT and aPTT tests. A MEMS based microfluidic device enabling both tests with one sample is a promising tool for Point-ofCare.
In our previous studies, we conducted blood plasma viscosity measurements through phase measurements with high sensitivity using the proposed scheme 21, 22 . During blood coagulation, a sudden change in the blood plasma viscosity occurs due to fibrin generation 13 . By monitoring the viscosity over a course of time, sudden increase in viscosity can be used as an indication of coagulation time for the given sample. In this study we have introduced a novel method using the microcantilevers and the sensing method for fast and convenient blood coagulation time measurements. To our knowledge, this is the first study using dynamic-mode cantilevers for coagulation time monitoring. The principle of the assay was introduced and the assay was tested with known plasma controls and the results are compared with reference datasheet and reference commercial device. Additionally, for further implementation, the microfluidic channels of cartridge are functionalized for PT and aPTT tests by drying specific reagents in each channel. PT and aPTT testing of control plasma samples revealed that coagulation times could be successfully detected for normal and abnormal plasma controls.
Materials and Methods

Sensor and cartridge fabrication
Sensor and Cartridge fabrication was performed using a procedure as reported in our earlier studies 21, 23, 24 . Briefly the nickel cantilevers were fabricated by a simple, one mask process utilizing sputter, photolithography, electrodeposition and wet etching steps. The fabricated nickel cantilevers had 200 μm length, 20 μm width and 2 μm thickness. These dimensions were chosen to keep the resonant frequency within the operating frequency of the lock-in amplifier that was used in the experiments.
After the microfabrication, the MEMS dies were placed into microfluidic cartridge. The microfluidic cartridge is consisting of two parts: the substrate and the lid. Both of the parts are made of poly methyl methacrylate (PMMA) and the specific geometries on each are patterned by precision machining. We bonded MEMS dies into the wells on the substrate. UV cured epoxy (Norland Optical Adhesive 81) was used for bonding. The microfluidic channels are patterned on the lid part. Each microchannel has 200 um depth and 1 mm width. These channels can be functionalized for different tests. The lid and substrate are bonded to each other by UV cured epoxy. This type of epoxy bonding also provides excellent sealing between the parallel channels. Each channel has a total volume of 10 µl. This volume can be further reduced with optimized cartridge geometry.
Measurement setup
The schematic of the experimental setup and the principle of operation were shown in Fig. 1a . The PMMA cartridge contains the MEMS dies with 2.5mm x 2.5 mm size. The nickel cantilevers are actuated magnetically with a coil placed in close proximity of the backside of the PMMA flow cell 21 . The coil is driven with a high power broadband current amplifier. Since no direct electrical contacts are required on the chip, magnetic actuation with an external coil has a significant advantage for in-liquid operation. The optical read-out can also be conducted remotely with laser-based techniques. The results presented in this study are obtained with a Laser Doppler Vibrometer (LDV). The vibration amplitudes are measured with a LDV. Optical measurement techniques based on grating interferometer, and knife-edge methods have also been successfully implemented in our group. Therefore, the LDV can be changed with other techniques to provide measurement parallelism 21, 25 . The phase difference between the coil drive and LDV is monitored with a Lock-in Amplifier (Zurich Instruments HF2LI) and recorded simultaneously using a Labview interface. All experiments are conducted at 37±0.1 o C.
Temperature stability is an important aspect since it has a strong effect on viscosity 26 . A temperature controller unit was built around the cartridge as shown in Fig. 1b . The unit consists of an AD590 temperature sensor, a controller circuit and heating wires entangled inside the aluminium block as shown in Fig. 1b . The system is capable of controlling the temperature with a 0.1 o C precision on the microfluidic channel.
PT and aPTT measurements with control plasma samples
PT and aPTT measurements were performed using healthy donor's plasma samples and commercially available control plasma samples. Thromboplastin is mixed with 10 μl of plasma and a stop watch started (t=0). After mixing the mixture is introduced to the system like in the aPTT test.
The PT and aPTT were calculated when the slope of the first-order derivative of the coagulation curve, recorded from change of the phase was maximal.
Sample preparation for scanning electron microscopy (SEM)
Samples were prepared as described for the test on the MEMS chip and then fixed for 4 h in 2.5% glutaraldehyde at room temperature.
Dehydration with increasing ethanol concentrations (30%-100 % v/v) was followed by drying. The samples were coated with 3 nm Au-Pd and imaged by Zeiss Ultra Plus FE-SEM.
Results and Discussion
Characterization of the system
When the cantilevers are operated in a viscous liquid media, the viscosity influences the resonant frequency and the quality factor of the system. In our previous works we measured the viscosity changes with a sensitivity of 0.01 cP, by tracking frequency at constant phase difference 21 or by tracking phase changes at constant frequency 22 . During blood coagulation a sudden change in blood plasma viscosity occurs. When the coagulation is initialized, thrombin acts on fibrinogens that result in the fibrin generation, then fibrins aggregate and form insoluble clots. After coagulation measurement, MEMS chips were investigated with SEM and clot formation was clearly observed on MEMS cantilevers (Fig. 2) . Changes in the viscosity of plasma were caused by the formation of the fibrin clot 14 , and we monitored this significant change in the viscosity by real-time tracking of the phase and amplitude. Before the coagulation measurements we characterized the system in air, Deionized (DI) water and blood plasma. Fig. 3 shows the frequency response and the phase of the system in different mediums. The resonant frequency of the cantilever is 39206 Hz when it is operated in air. Also the Quality Factor (Q) is around 178. However when it was operated in DI water the frequency drops down to 22185 Hz and the Q is around 5. This harsh decrease is due to hydrodynamic loading which has both inertial and viscous components 27 . The response in blood plasma before coagulation is similar to DI water. The resonant frequency is 20267 and the Q is around 3.6. This is due to the higher viscosity and density of blood plasma with respect to DI water. Detailed information can be obtained from our previous studies on blood plasma viscosity 21, 22 . During blood coagulation, a sudden change in the blood plasma viscosity occurs due to fibrin generation 13 . This kind of viscosity change creates an increase in the hydrodynamic loading of the vibrating structures in viscous liquids according to Sader's theory 27 . For example, increasing viscosity reduces the vibration amplitude of the vibrating mechanical structure driven by a constant amplitude. Also, the effect of viscosity change can be observed as a phase shift between the drive signal and the phase of the mechanical displacement. Depending on the drive frequency the phase shift could be either positive or negative. The effect of viscous loading on mechanical resonators have been further investigated in the literature [28] [29] [30] . After coagulation, the quality factor and the resonant frequency is changed. The significant difference in the phase curve after the coagulation is shown in Fig. 3a . According to our method we excited the system at a certain frequency around the resonant peak. The phase difference at that certain frequency changed during coagulation. Hence simultaneous monitoring of the phase gave a unique signature which indicates the coagulation time. Fig. 3b shows the long-term phase stability of the system in citrated blood plasma. The cantilever was driven at its resonant frequency. The phase was recorded for 30 minutes. The standard deviation of the phase during this measurement is 0.015 o which can be defined as the noise floor of the system. As will be shown during coagulation measurements, this value is highly sufficient for sensing blood coagulation.
Experimental Procedure
In this study we conducted both the aPTT and PT tests with our system. In order to investigate the sensitivity and reproducibility of the system, we used commercially available control plasma samples. The phase and amplitude of the system during a PT test is shown in Fig. 4a . The sharp change of the phase and amplitude during coagulation can be seen. The first 5 seconds is the time passed during the mixing of reagent and plasma and introducing the mixture to the system. The amplitude data is noisier than the phase read-out. This can be related with the relatively small vibration amplitudes. The RMS value of the displacement is in the order of 10 nm. This is a very small value compared to cantilever dimensions (Length: 200µm, Width: 20µm, Thickness: 2 µm). Also during coagulation, as a result of increased viscosity, the vibration is being damped and the amplitude decreases to even lower values. The amplitude readout is susceptible to the environmental noise. However the phase read-out approach is more immune to external noise sources since a reference signal (coil input) is being used. Phase gives clearer information since the Signal-to-Noise Ratio (SNR) is higher. It is more convenient to use phase for tracking coagulation.
After the data is collected a polynomial is fitted to the phase data which is shown in Fig. 4b . The first derivative of this polynomial is used to obtain quantitative data. The time where the derivative is zero (df/dt→0) indicates the coagulation start time whereas the local minimum (df/dt→min.) shows the midpoint of the coagulation process (Fig. 4b) . In Fig. 4c the fit functions obtained from the repetitive PT measurements with Normal, Abnormal1 and Abnormal2 plasma are shown. Fig. 4d shows the first derivatives of these functions. The difference between the coagulation times with different samples can be seen. They can be clearly distinguished from each other. The same data acquisition and processing protocol is also applied in aPTT measurements. After the measurements, the values are normalized with respect to the mean value of the normal plasma sample. The commercial devices report the coagulation times in terms of International Normalized Ratio (INR) 5 . There will be a variation between the test results (in seconds) of a normal individual. This is due to the variations in the batches of reagent and test conditions. The INR is devised to standardize these results. It is related between the tested individual's PT time and normal PT time 20 . International Normalized Ratio (INR) for PT measurements and normalized ratio for the aPTT measurements are obtained. The mean value, standard deviation and coefficient of variation for the PT and aPTT measurements are shown in Table 1 . The start-point of the coagulation obtained with our system has a better coherence with the reference data than the coagulation mid-point. Also another reference PT measurement is conducted with a reference commercial device CoaguCheck XS. Again the coagulation times are in a good agreement with the commercial reference device measurements. Our proposed novel assay can significantly differentiate coagulation times between normal, abnormal 1, and abnormal 2 samples (p<0.01). A reliable diagnostic assay should yield the same measurements for the same target. Various sources of variability affect overall cartridge variability: electronic and fabrication chip-to-chip variability, and biological assay variability. All three of these variability sources contributed to the overall measurement variability. To check the reproducibility of the assay, all the measurements were repeated three times in a day and in three different days. The percent coefficient of variation (CV %) for the tested samples are 7.28 and 6.33 for PT and aPTT measurements, respectively. These reproducibility values are comparable with the commercial devices available in the market 31 and recent studies in the literature 20 . The results for aPTT and PT measurements in comparison with the reference value are shown in Fig. 5 . There is no statistical difference between our results and those of reference device and control samples data sheet (p > 0.05).
Measurements with surface functionalized channels: All above measurements were performed with samples prepared outside the cartridge and placed on MEMS chips. For further implementation, the microfluidic channels of cartridge are functionalized for PT and aPTT tests by drying specific reagents in each channel. Then we performed PT and aPTT measurements with surface functionalized cartridges. The surface functionalized channels of the cartridge are shown in Fig. 6a . For the aPTT Test, Micronised Silica Platelet Solution (Lot No: SP63, DIAGEN, UK) was used whereas for the PT Test Freeze Dried Rabbit Brain Thromboplastin (Lot No: DT139, DIAGEN, UK) was used. Briefly, 10 µl of each solution was poured into the microchannels. 10 µl of 25 mM CaCl 2 was also poured into the channels at the opposite side (Fig. 6a) . Afterwards the cartridge was placed into a vacuum chamber for drying. The vacuum drying operation was conducted at around 100 mmHg vacuum for 20 min to dry the reagents. For each test 10 µl of blood plasma sample at 37 o C is poured into the reagent coated channel. For aPTT test 5 min of incubation is chosen whereas for the PT test this time is 1 min. After the incubation, the sample is pushed to the opposite channel that is coated with CaCl 2 . When the sample touches to the channel walls, the sample is pulled back to the cantilever site and the clock is started (t=0). Real-time phase and amplitude read-out was conducted. Though the tests are conducted one at a time within the scope of this paper, tests can be performed simultaneously using multiple photodetectors for the readout. Since the electromagnetic actuation is at a constant frequency, using a detector array will enable simultaneous monitoring of the phases of different cantilevers in parallel channels. The results of the PT and aPTT test proceeded on the same cartridge is shown in Fig.  6b . As expected, when the coagulation started a sharp change in the phase was observed. The reference curve is obtained by addition of Ca 2+ to the citrated blood plasma. According to the first derivative of the phase data the coagulation time is 645s for the reference channel. This is an expected value since no external reagent is added to the system. According to the first derivative of the phase data the coagulation time for aPTT test was 67s whereas for PT test it was 22s. According to the reference values in the reagent datasheets these values supposed to be between 35-40s and 14-17s for aPTT and PT tests, respectively. This slight difference was probably due to reagent mixing inefficiency in microchannels and further improvements are needed to obtain more accurate PT and aPTT values. 
